- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2012
- Public Summary Document (PSD) November 2012 PBAC Meeting - PDF
Rivaroxaban – November 2012
Rivaroxaban, tablets, 15 mg and 20 mg, Xarelto®
Last updated
8 November 2023